Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases ...
A 34-year-old Caucasian woman was referred for evaluation of progressive skin tightening involving her extremities. Cutaneous ...
While seizures are alarming to witness, understanding what they are and what they mean for your dog is the first and most ...
GRASP is a new gradient-based planner for learned dynamics (a “world model”) that makes long-horizon planning practical by (1 ...
Abstract: This paper considers the multi-robot task allocation problem for persistent monitoring over large dispersed areas. The problem is formulated as a binary optimization problem with nonsmooth ...
Experts explain why occasional forgetfulness is common—but persistent memory loss could signal depression, mild cognitive ...
Morning Overview on MSN
Study flags frequent long naps in older adults as a possible health warning sign
When a 75-year-old starts dozing on the couch for two hours every afternoon, family members tend to shrug it off as a normal ...
The FDA has granted an accelerated approval for Otarmeni (lunsotogene parvec-cwha), the first gene therapy to treat patients ...
Approval in severe-to-profound and profound OTOF -related hearing loss is based on pivotal results of the CHORD trial demonstrating 80% of ...
Balancing copyright protection and artistic freedom: the purpose of the pastiche exception. In explaining the objective of Article 5(3)(k), the CJEU emphasised that the exception ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results